Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lea Wagmann

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Metabolites|December 23, 2022
In Vitro and In Vivo Toxicometabolomics of the Synthetic Cathinone PCYP Studied by Means of LC-HRMS/MSSelina Hemmer, Lea Wagmann, Benedikt Pulver, et al.
Toxins|October 29, 2020
Analysis of α- and β-amanitin in Human Plasma at Subnanogram per Milliliter Levels by Reversed Phase Ultra-High Performance Liquid Chromatography Coupled to Orbitrap Mass SpectrometryThomas P Bambauer, Lea Wagmann, Armin A Weber, et al.
Drug Testing and Analysis|June 3, 2021
Further development of a liquid chromatography-high-resolution mass spectrometry/mass spectrometry-based strategy for analyzing eight biomarkers in human urine indicating toxic mushroom or Ricinus communis ingestionsThomas P Bambauer, Lea Wagmann, Armin A Weber, et al.
Drug Testing and Analysis|March 15, 2021
Abuse of nutmeg seeds: Detectable by means of liquid chromatography-mass spectrometry techniques?Sascha K Manier, Lea Wagmann, Armin A Weber, et al.
Clinical Chemistry and Laboratory Medicine|April 3, 2023
Simultaneous analysis of antihyperglycemic small molecule drugs and peptide drugs by means of dual liquid chromatography high-resolution mass spectrometryAline C Vollmer, Lea Wagmann, Armin A Weber, et al.
Toxicology|January 10, 2026
In vivo and in vitro toxicokinetics including metabolism, isozyme mapping, and monoamine oxidase inhibition of three (2-aminopropyl)benzo[b]thiophene (APBT) psychedelicsLea Wagmann, Simon D Brandt, Pierce V Kavanagh, et al.
Archives of Toxicology|February 4, 2025
Toxicokinetics and analytical toxicology of the phenmetrazine-derived new psychoactive substance 3,4-methylenedioxyphenmetrazine studied by means of in vitro systemsMatthias D Kroesen, Tanja M Gampfer, Lea Wagmann, et al.
Journal of Analytical Toxicology|September 9, 2022
In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists 2F-QMPSB and SGT-233 Including Isozyme Mapping and Carboxylesterases Activity TestingMatthias J Richter, Lea Wagmann, Simon D Brandt, et al.
Metabolites|December 30, 2020
Liquid Chromatography-High-Resolution Mass Spectrometry-Based In Vitro Toxicometabolomics of the Synthetic Cathinones 4-MPD and 4-MEAP in Pooled Human Liver MicrosomesSascha K Manier, Florian Schwermer, Lea Wagmann, et al.
Molecules (Basel, Switzerland)|April 3, 2021
Assessing Adherence to Antihypertensive Medication by Means of Dose-Dependent Reference Plasma Concentration Ranges and Ultra-High Performance Liquid Chromatography-Ion Trap Mass Spectrometry AnalysisLea Wagmann, Aline C Vollmer, Lucas Lauder, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Metabolites|December 23, 2022
In Vitro and In Vivo Toxicometabolomics of the Synthetic Cathinone PCYP Studied by Means of LC-HRMS/MSSelina Hemmer, Lea Wagmann, Benedikt Pulver, et al.
Toxins|October 29, 2020
Analysis of α- and β-amanitin in Human Plasma at Subnanogram per Milliliter Levels by Reversed Phase Ultra-High Performance Liquid Chromatography Coupled to Orbitrap Mass SpectrometryThomas P Bambauer, Lea Wagmann, Armin A Weber, et al.
Drug Testing and Analysis|June 3, 2021
Further development of a liquid chromatography-high-resolution mass spectrometry/mass spectrometry-based strategy for analyzing eight biomarkers in human urine indicating toxic mushroom or Ricinus communis ingestionsThomas P Bambauer, Lea Wagmann, Armin A Weber, et al.
Drug Testing and Analysis|March 15, 2021
Abuse of nutmeg seeds: Detectable by means of liquid chromatography-mass spectrometry techniques?Sascha K Manier, Lea Wagmann, Armin A Weber, et al.
Clinical Chemistry and Laboratory Medicine|April 3, 2023
Simultaneous analysis of antihyperglycemic small molecule drugs and peptide drugs by means of dual liquid chromatography high-resolution mass spectrometryAline C Vollmer, Lea Wagmann, Armin A Weber, et al.
Toxicology|January 10, 2026
In vivo and in vitro toxicokinetics including metabolism, isozyme mapping, and monoamine oxidase inhibition of three (2-aminopropyl)benzo[b]thiophene (APBT) psychedelicsLea Wagmann, Simon D Brandt, Pierce V Kavanagh, et al.
Archives of Toxicology|February 4, 2025
Toxicokinetics and analytical toxicology of the phenmetrazine-derived new psychoactive substance 3,4-methylenedioxyphenmetrazine studied by means of in vitro systemsMatthias D Kroesen, Tanja M Gampfer, Lea Wagmann, et al.
Journal of Analytical Toxicology|September 9, 2022
In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists 2F-QMPSB and SGT-233 Including Isozyme Mapping and Carboxylesterases Activity TestingMatthias J Richter, Lea Wagmann, Simon D Brandt, et al.
Metabolites|December 30, 2020
Liquid Chromatography-High-Resolution Mass Spectrometry-Based In Vitro Toxicometabolomics of the Synthetic Cathinones 4-MPD and 4-MEAP in Pooled Human Liver MicrosomesSascha K Manier, Florian Schwermer, Lea Wagmann, et al.
Molecules (Basel, Switzerland)|April 3, 2021
Assessing Adherence to Antihypertensive Medication by Means of Dose-Dependent Reference Plasma Concentration Ranges and Ultra-High Performance Liquid Chromatography-Ion Trap Mass Spectrometry AnalysisLea Wagmann, Aline C Vollmer, Lucas Lauder, et al.
Pageof 8